Vasculitis Trial, Recruiting (NCT04102930)

Vasculitis Trial, Recruiting NCT04102930 Sponsor: University of Leeds Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT04102930 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing to identify which ethnic group you belong to (for example, Caucasian, Asian, or Afro-Caribbean).
You have been diagnosed with Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR), or if you are being assessed now, your doctor believes GCA or PMR is the most likely explanation for your symptoms.
You are able and willing to agree to take part after being fully informed about the trial, and you are aged 50 or over (unless your GCA has been confirmed by a biopsy and your case is considered a very clear-cut example of GCA — confirm with trial site).

Who may not be able to join:

You are not willing or not able to give your full informed consent to take part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ann Morgan, University of Leeds

Phone: 0113 343 7764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04102930

Sponsor: University of Leeds

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: 0113 343 7764

More information: https://clinicaltrials.gov/study/NCT04102930

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing to identify which ethnic group you belong to (for example, Caucasian, Asian, or Afro-Caribbean).
You have been diagnosed with Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR), or if you are being assessed now, your doctor believes GCA or PMR is the most likely explanation for your symptoms.
You are able and willing to agree to take part after being fully informed about the trial, and you are aged 50 or over (unless your GCA has been confirmed by a biopsy and your case is considered a very clear-cut example of GCA — confirm with trial site).

Who may not be able to join:

You are not willing or not able to give your full informed consent to take part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Leeds

Registry

ClinicalTrials.gov

Start date

10 June 2005

Est. completion

31 March 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Primary outcome for genetic susceptibility studies:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov